Literature DB >> 3449478

Electron beam therapy for eyelid carcinomas.

C Sinesi1, M D McNeese, L J Peters, H Goepfert, J Kong, M D Mills.   

Abstract

Forty-six (85%) basal cell and eight (15%) squamous cell carcinomas of the eyelids were treated with electron beams between 1963 and 1983. Lesion sizes ranged from microscopic to 4 cm, with 28 lesions larger than 1 cm. Thirty-eight lesions were treated with radiotherapy after incisional biopsy, and 16 were treated after excisional biopsy (specimens showed positive margins). Doses varied from 45 to 72 Gy, with daily fractions ranging from 2.12 to 4.0 Gy. There were six disease recurrences (10.9%): three in the treatment field and three at the treatment margin. Four of six recurrences were subsequently controlled by limited surgical excision and repair with preservation of the eye, whereas the other two required enucleation. Treatment sequelae such as skin atrophy, telangiectasis, and cosmetic results were evaluated in terms of radiotherapy parameters, pretreatment surgery, and size of the lesion. In 44 patients, the overall cosmetic result was judged as good to excellent, five patients had a mild to modest degree of deformity, and five had significant deformity. Such deformity was usually associated with tumor destruction or previous surgery. No major complications were noted.

Entities:  

Mesh:

Year:  1987        PMID: 3449478     DOI: 10.1002/hed.2890100106

Source DB:  PubMed          Journal:  Head Neck Surg        ISSN: 0148-6403


  1 in total

1.  Reirradiation for Recurrent Scalp Angiosarcoma: Dosimetric Advantage of PBT over VMAT and EBT.

Authors:  Tal Eitan; Nicholas J Damico; Rajesh Pidikiti; Michael Z Kharouta; Donald Dobbins; Frederick B Jesseph; Mark Smith; Ankit Mangla; Theodoros N Teknos; David B Mansur; Mitchell Machtay; Min Yao; Aashish D Bhatt
Journal:  Int J Part Ther       Date:  2019-12-16
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.